Experienced Drug Development Leadership

Thomas I. Bradshaw, BA, MBA

CEO & Co-Founder

  • MBA, Harvard
  • Serial biotech entrepreneur · Core IP inventor
  • Built & sold Ricerca to Bain Capital

tom@neuronasal.com

Douglas A. Greene, MD

Head of R&D

  • AB Princeton, MD Johns Hopkins
  • FDA Endocrinology Committee Chairman
  • EVP Merck
  • SVP & CMO Sanofi
  • 200+ publications

Joseph Hulihan, MD

Chief Medical Officer

  • MD Drexel
  • Board-certified neurologist
  • CMO Marinus (ganaxolone)
  • PI on 25+ trials
  • 70+ publications
  • 3,000+ citations

Michael Kaufman

VP Business Dev & Commercialization

  • Licensing & partnerships expert
  • Strategic partnerships & commercialization
  • Licensing, M&A, investor relations

michael@neuronasal.com

Board & Corporate Advisors

Steven H. Rouhandeh

Executive Chairman

  • JD Harvard Law, BA Southern Illinois
  • CIO, SCO Capital Partners (life sciences) since 1997
  • Chair, Abeona 2008–2021
  • VP Investment Banking, Deutsche Bank
  • Attorney, Cravath Swaine & Moore

Scientific Advisors

Christine Berni-Silverstein

Vice Chairman

  • Accounting & Finance, Saint John’s University
  • CFO: Artios, Excision BioTherapeutics, Emendo
  • Board: Abeona Therapeutics, Marinus Pharmaceuticals

Rajiv Ratan, MD PhD

Chair, Scientific Advisory Board & Co-inventor

  • MD PhD Yale, AB Amherst
  • Executive Director, Burke Neurological Institute
  • Prof. Neurology, Weill Cornell
  • Oxidative stress, neuroprotection

Barry Hoffer, MD PhD

Parkinson’s Disease Expert

  • Prof. Neuroscience & Pharmacology, Case Western Reserve University
  • Dopamine neurons, PD, neurodegeneration

Raymond Swanson, MD

Oxidative Stress & Neuronal Mechanisms Expert

  • Prof. of Neurology, UC San Francisco
  • Stroke, brain injury, oxidative stress & neuronal death mechanism

Maral Mouradian, MD

Parkinson’s Disease Therapeutics Expert

  • William Dow Lovett Prof. of Neurology, Rutgers
  • Director, Rutgers Institute for Neurological Therapeutics

Caroline Tanner, MD PhD

Parkinson’s Disease Expert

  • Prof. of Neurology, UC San Francisco
  • Leading clinical researcher in PD epidemiology

Charalampos Tzoulis, MD PhD

Parkinson’s Disease & Neurogenetics Expert

  • Prof. Neurology & Neurogenetics, Univ. of Bergen
  • Implemented a PD Drug Evaluation & Dev. Platform
  • Director, K.G. Jebsen Center for PD
  • Haukeland University Hospital

Richard Wyse

Parkinson’s Research & Development Expert

  • Director, Research Development, Cure Parkinson’s
  • Translating scientific discoveries into PD clinical trials
  • Bridges academia, biotech, and pharma